Morning Overview on MSN
An old asthma inhaler drug just reversed advanced fatty liver damage in the lab — and doctors are now racing it into human trials
Roughly 115 million adults worldwide are estimated to have metabolic dysfunction-associated steatohepatitis, or MASH, a ...
Please provide your email address to receive an email when new articles are posted on . Less than 40% of the studied veteran cohort were adherent to their inhaled COPD medications. Adherence was found ...
What type of asthma inhaler is right for you? In the U.S., 25 million people are affected by asthma. That’s roughly 1 in 13 adults and children. Asthma can be mild or severe. Some people with asthma ...
Editor's note: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...
Please provide your email address to receive an email when new articles are posted on . Invited patients had 32% of days covered for maintenance inhalers, whereas control patients had a smaller ...
Leah J. Witt, MD: Hello. I'm Dr Leah Witt. Welcome to season one of Medscape InDiscussion, chronic obstructive pulmonary disease (COPD) podcast series. Today we're talking medications, especially ...
Despite being one of the most effective treatments for asthma, inhalers are still feared, delayed, or misunderstood by many patients. From myths about addiction and steroids to social stigma and poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results